HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry.

Source:http://linkedlifedata.com/resource/pubmed/id/16681686

Download in:

View as

General Info

PMID
16681686